FindTrial
Sign In

Study on new biomarkers and models for predicting the outcomes of low-grade squamous intraepithelial lesion (LSIL) of cervix

Study on new biomarkers and models for predicting the outcomes of low-grade squamous intraepithelial lesion (LSIL) of cervix

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056018
Enrollment
Unknown
Registered
2022-01-30
Start date
2022-02-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical intraepithelial lesions

Interventions

case series:Nil

Sponsors

Women's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with cervical histopathological diagnosis of LSIL for the first time after colposcopy biopsy and followed up without surgical treatment were included in the study.

Exclusion criteria

Exclusion criteria: 1.Patients diagnosed with cervical CIN, cervical cancer or other malignant tumors in the past; 2.Incomplete cervix and partial or total excision of cervix in the past; 3.Less than 25 years or more than 65 years; 4.Pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
Biomarkers in cervical exfoliated cells;—

Countries

China

Contacts

Public ContactCheng Xiaodong

Women's Hospital, Zhejiang University School of Medicine

chengxd@zju.edu.cn+86 13958039839

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026